The Global Surrogacy Market Size Was Valued at USD 38.2 Billion in...

The Global Surrogacy Market Size Was Valued at USD 38.2 Billion in 2023 and is Projected to Reach USD 276.52 Billion by 2032

Postado 2025-12-08 07:39:40

The Global Surrogacy Market Size Was Valued at USD 38.2 Billion in 2023 and is Projected to Reach USD 276.52 Billion by 2032, Growing at a CAGR of 24.6% From 2024-2032.

The Surrogacy Market encompasses the specialized segment of the Assisted Reproductive Technology (ART) industry, defined by services connecting intended parents with surrogate mothers to facilitate pregnancy and delivery. This market addresses critical reproductive needs, primarily serving couples struggling with infertility, single parents, and same-sex couples seeking biological family creation. The core services involve medical procedures like in-vitro fertilization (IVF), legal contract management, psychological screening, and financial coordination.

A key advantage of surrogacy over other family-building alternatives is its high success rate in achieving biological parenthood for intended parents who cannot carry a pregnancy themselves due to medical or social reasons. This method provides legal clarity and genetic linkage to the child, which is often preferred over adoption. The main industries driving the growth of this market are specialized fertility clinics, large hospital networks with dedicated IVF centers, and international surrogacy agencies that manage complex cross-border arrangements.

👉 To request a sample report:

https://introspectivemarketresearch.com/request/17524

Market Segmentation

The Surrogacy Market is segmented into Product Type, Technique, and End-Use. By Product Type, the market is categorized into (Gestational Surrogacy and Traditional Surrogacy). By Technique, the market is categorized into (In-vitro Fertilization (IVF) and Intrauterine Insemination (IUI)). By End-Use, the market is categorized into (Fertility Clinics, Hospitals, and Surrogacy Agencies & Consultancies).

Growth Driver

The principal growth driver for the Surrogacy Market is the soaring global incidence of infertility, which is affecting a growing percentage of the reproductive-age population worldwide due to factors such as delayed childbearing, lifestyle changes, and rising chronic health issues. This demographic pressure is compounded by the increasing global acceptance and subsequent legalization of surrogacy for diverse family structures, including LGBTQ+ and single-parent households, particularly in Western nations and parts of Asia. As legal pathways become clearer and more regulated, the demand for these high-cost, high-success services accelerate significantly, underpinning the strong projected CAGR.

Market Opportunity

A significant market opportunity lies in the standardization of global legal and ethical frameworks for commercial surrogacy. Currently, complex and conflicting international laws create logistical and legal hurdles, leading to cross-border parental order disputes. Manufacturers and service providers have a high-growth avenue in developing technology-driven matching platforms that use AI and advanced data analytics to efficiently and ethically pair intended parents with suitable surrogates based on comprehensive medical, legal, and psychological criteria. This innovation reduces wait times and improves the emotional journey for all parties, unlocking previously underserved market segments.

Detailed Segmentation

Title: Surrogacy Market, Segmentation Line below: The Surrogacy Market is segmented on the basis of Product Type, Technique, and End-Use.

Product Type

The Product Type segment is further classified into Gestational Surrogacy and Traditional Surrogacy. Among these, the Gestational Surrogacy sub-segment is expected to hold the highest market share in 2024. This dominance is overwhelmingly driven by the fact that in gestational surrogacy, the surrogate mother has no genetic link to the child. This separation of biological and legal parenthood simplifies the legal process, reduces potential emotional conflicts, and makes it the preferred and often legally mandated method in jurisdictions where commercial surrogacy is permitted. Its necessity in the prevailing IVF procedure ensures its continued market leadership and premium pricing.

Technique

The Technique segment is further classified into In-vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Among these, the In-vitro Fertilization (IVF) sub-segment is expected to hold the highest market share in 2024. IVF is the foundational technique used in almost all gestational surrogacy arrangements, which is the dominant product type globally. It allows the intended parents to use their own or donor eggs and sperm to create an embryo, which is then transferred to the surrogate. The high reliability and the ability to perform preimplantation genetic testing (PGT) before transfer ensure IVF's continued position as the most effective and utilized technique in the market.

Some of The Leading/Active Market Players Are-

Circle Surrogacy & Egg Donation (USA)

Growing Generations (USA)

· The intended Parent's Surrogacy Agency (USA)

· ConceiveAbilities (USA)

· Reproductive Law Center (USA)

· IVF Babble (UK)

· CooperSurgical, Inc. (USA)

· Ferring Pharmaceuticals (Switzerland)

· In Vitro Fertilisation (IVF)

· Australia (Australia)

· New Hope Fertility Center (USA)

· Nova IVI Fertility (India)

· CARE Fertility Group (UK)

· Tammuz Family (Israel)

· The Samitivej Hospital Network (Thailand) and other active players.

Key Industry Developments

In May 2024, The State of New York expanded its surrogacy legislation, fully protecting the rights of intended parents and surrogates and establishing clear legal pathways for compensation. This achievement is significant as the legislative clarity reduces the need for citizens to seek surrogacy services internationally, boosting domestic market consumption, improving safety, and making the state a leading regulated hub for family building through ART.

In January 2025, CooperSurgical, Inc. announced a partnership with a leading genomics company to integrate advanced Preimplantation Genetic Testing (PGT) specifically for surrogacy cases. The new system allows for rapid, comprehensive screening of embryos before transfer. This advancement is crucial as it significantly increases the success rates of the initial embryo transfer to the surrogate, reducing the overall number of cycles required and lowering the total cost and time commitment for intended parents.

Key Findings of the Study

Dominant Segments: Gestational Surrogacy (Type) and Fertility Clinics (End-Use) lead by revenue.
Leading Regions: North America holds the largest share, with Asia-Pacific showing the fastest growth.
Key Growth Drivers: Rising global infertility and increased societal acceptance of diverse family models.
Market Trends: Focus on regulating cross-border surrogacy and adopting AI for enhanced parent-surrogate matching.

🔍 𝐈𝐧-𝐃𝐞𝐩𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭:

https://introspectivemarketresearch.com/reports/surrogacy-market/

About Introspective Market Research

Introspective Market Research is a global provider of data-driven market intelligence and strategic advisory services. Our analysts and consultants deliver comprehensive reports, actionable insights and customized consulting to clients across chemicals & materials, healthcare, energy, environment, infrastructure, and advanced manufacturing sectors.